A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2011
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2337328C Biocompatible polymers, preparation method and compositions containing same
10/13/2011	WO2011127482A2 Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related thereto
10/13/2011	WO2011127393A2 Variants of ancestral uricases and uses thereof
10/13/2011	WO2011127106A1 Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators
10/13/2011	WO2011127051A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/13/2011	WO2011126882A2 Therapeutic peptides and their derivatives and therapeutic uses thereof
10/13/2011	WO2011126833A2 Anti-inflammatory factors
10/13/2011	WO2011126342A2 Novel use of polygonatum falcatum or polygonatum sibiricum extract
10/13/2011	WO2011126099A1 Prophylactic agent or therapeutic agent for diabetes or obesity
10/13/2011	WO2011125910A1 Calcium preparation and production method therefor
10/13/2011	WO2011123994A1 Traditional chinese medicine composition for treating hyperglycemia and preparation method thereof
10/13/2011	WO2011087857A3 Compositions and methods for treating obesity and diabetes
10/13/2011	WO2011066484A9 Isoxazoline compounds in type 2 diabetes and other maladies
10/13/2011	WO2011049344A3 Method of preparing sitagliptin and intermediates used therein
10/13/2011	WO2011043630A3 Composition for preventing and treating obesity diseases containing highly water-soluble 2-hydroxypropyl-β-cyclodextrin as active ingredient
10/13/2011	WO2011034951A3 Assisted enzyme replacement therapy
10/13/2011	US20110251276 Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
10/13/2011	US20110251275 Omega-3 fatty acids for reduction of lp-pla2 levels
10/13/2011	US20110251261 Compositions and methods for inhibition of nucleic acids function
10/13/2011	US20110251253 Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
10/13/2011	US20110251248 Glucagon receptor antagonist compounds
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251237 2,5-Disubstituted Piperidine Orexin Receptor Antagonists
10/13/2011	US20110251236 Galactokinase inhibitors
10/13/2011	US20110251226 Cyclohexylamin isoquinolone derivatives
10/13/2011	US20110251225 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/13/2011	US20110251221 Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators
10/13/2011	US20110251218 Novel compounds
10/13/2011	US20110251211 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
10/13/2011	US20110251207 Biaryl-spiroaminooxazoline analogues as alpha 2c adrenergic receptor modulators
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/13/2011	US20110251204 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251203 Use of pkc inhibitors in diabetic complications
10/13/2011	US20110251187 Heterocyclic compound
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251176 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	US20110251173 Chemical compounds
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251155 Methods of Using Diacerein as an Adjunctive Therapy for Diabetes
10/13/2011	US20110251144 Molecular modulators of the wnt/beta-catenin pathway
10/13/2011	US20110251138 Lipoic acid metabolite conjugate: preparation and their therapeutic effect
10/13/2011	US20110251125 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/13/2011	US20110251123 Oral pharmaceutical composition of desmopressin
10/13/2011	US20110251122 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
10/13/2011	US20110251121 Use of cysteine-rich whey derived protein in patients receiving chemotherapy and/or radiotherapy to improve patient survival
10/13/2011	US20110250287 One step removal of selected molecules from body fluid and tissue
10/13/2011	US20110250280 Microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type i diabetes mellitus
10/13/2011	US20110250273 Compositions of proton pump inhibitors, kits and methods of their use to treat diabetes
10/13/2011	US20110250271 Spaced drug delivery system
10/13/2011	US20110250270 Compositions containing a capillary-active system with application-relevant diffferentiability and their use
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250243 Nanoparticle compositions
10/13/2011	US20110250240 Immune enhancing compositions and methods of use thereof
10/13/2011	US20110250238 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract
10/13/2011	US20110250231 Method of using punicic acid to enhance immune response and prevent metabolic disorders
10/13/2011	US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
10/13/2011	US20110250208 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
10/13/2011	US20110250206 Markers for determination of patient responsiveness
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250197 Pharmaceutical combination
10/13/2011	US20110250187 Compositions and methods for treating hypophosphatasia
10/13/2011	US20110250153 Oligomeric biosurfactants in dermatocosmetic compositions
10/13/2011	US20110250142 Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
10/13/2011	CA2795750A1 Modulation of cetp expression
10/13/2011	CA2795732A1 Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators
10/13/2011	CA2795514A1 Novel hypoglycemic compounds
10/13/2011	CA2795513A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/13/2011	CA2794566A1 Methods of using diacerein as an adjunctive therapy for diabetes
10/12/2011	EP2374884A2 Human miRNAs isolated from mesenchymal stem cells
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011	EP2374794A1 Cyclic amine compounds
10/12/2011	EP2374788A1 Indanyl compounds
10/12/2011	EP2374507A1 Compositions and methods for treatment of body weight conditions with milk minerals, casein fractions and enzyme inhibitor
10/12/2011	EP2374468A1 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes
10/12/2011	EP2374453A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
10/12/2011	EP2374452A1 Nutrient composition
10/12/2011	EP2373679A2 Mini-hepcidin peptides and methods of using thereof
10/12/2011	EP2373673A1 Tgr5 modulators and methods of use thereof
10/12/2011	EP2373663A1 Thienopyridines as pharmacologically active agents
10/12/2011	EP2373652A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
10/12/2011	EP2373646A1 Phthalazinone and related analogs as sirtuin modulators
10/12/2011	EP2373324A1 Method of treatment of diseases using hoodia extracts
10/12/2011	EP2373299A2 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus
10/12/2011	EP2373183A1 Modulation of infant fat mass
10/12/2011	EP2229356B1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
10/12/2011	EP2094683B1 Bicyclic compounds and use as antidiabetics
10/12/2011	EP2077846B1 Benzoxazepine compounds, their preparation and use
10/12/2011	EP2001878B1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
10/12/2011	EP1853266B1 2s,4r ketoconazole for treating diabetes, metabolic syndrome and other conditions
10/12/2011	EP1761522B1 Compounds and methods for treating dyslipidemia
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216318A Antioxidant
10/12/2011	CN102216316A Substituted amine derivative and medicinal composition comprising same as the active ingredient
10/12/2011	CN102216281A Novel choline cocrystal of epalrestat
10/12/2011	CN102216276A Heteroaryls amide derivatives and their use as glucokinase activators
10/12/2011	CN102215853A Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field
10/12/2011	CN102215848A 鼠李糖乳杆菌和体重控制 Lactobacillus rhamnosus and weight control
10/12/2011	CN102215846A St cyr john a [us]; maccarter dean a
10/12/2011	CN102215839A Fat emulsion for artificially feeding seriously ill intensive care patients

1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 1298